latest news.

Cosette Pharmaceuticals Acquires Rights to Eight Branded Products from Daiichi Sankyo

Transformational Transaction Diversifies Cosette’s Business to Accelerate Future Growth


Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.


Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.


While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.


Cosette Pharmaceuticals Announces the launch of Griseofulvin Oral Suspension, 125 mg/5 mL.

Cosette Pharmaceuticals, Inc began shipping Griseofulvin Oral Suspension, 125 mg/5 mL…

Read More

Cosette Pharmaceuticals Appoints Kevin Hickey, Vice President, Brand Sales and Marketing to Accelerate Transformation

“We are very excited to have Kevin Hickey join our team. His tremendous experience in strategy and…

Read More